PRESS
IN THE NEWS
September 17, 2018
Interview – CEOCFO Magazine September 17, 2018 Issue
Q&A with Dr. Corey A. Carter, President and CEO of EpicentRx Inc. developing “smart” oncolytic virus therapies in combining immuno-oncology agents that activate the human immune system against cancer with minimal toxicity for patients
August 09, 2018
Radioprotectors: Defensive Weapons In The War On Cancer
